8-K current report · filed May 12, 2026

MAXCYTE, INC. (MXCT) 8-K Current Report: May 12, 2026

Short answer

MAXCYTE, INC. (MXCT) filed an 8-K current report with the SEC on May 12, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure). Q1 2026 results for quarter ended March 31, 2026 announced May 12, 2026.

MAXCYTE, INC. 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Q1 2026 results for quarter ended March 31, 2026 announced May 12, 2026
  • Full financial details contained in furnished Exhibit 99.1 press release
  • Disclosure furnished under Item 2.02, limiting Exchange Act Section 18 liability and incorporation into other filings

Item 7.01 · Regulation FD Disclosure

  • Updated corporate presentation posted May 12, 2026 for use in investor communications and conferences
  • Presentation available as Exhibit 99.2 and on MaxCyte’s investor website
  • Disclosure furnished, not filed, limiting Section 18 liability and automatic incorporation into other filings

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other MAXCYTE, INC. 8-K filings

Get the next MXCT 8-K as it lands

Follow MXCT for push alerts, or ask the research agent what this filing means.